Genomics market research reports and industry analysis
|
GPCRs in Drug Discovery - Efforts to De-Orphanize Novel GPCR Targets are Increasing
11/1/2011 | published by: GBI Research
... GPCR Targets are Increasing” which provides insights in to the technical and commercial importance of G protein coupled receptors, which are the most important category of receptors in the human body. The report provides a ...
|
read more...
|
$3,500.00
|
|
Epigenetic Therapies and Technologies: World Market Prospects 2011-2021
10/17/2011 | published by: Visiongain
... world, submarket, product and national levels to 2021. Through our research and analyses we aim to save you time and help in your decisions. You can see how existing epigenetic therapies will perform to 2021. ...
|
read more...
|
$2,739.00
|
|
MicroRNA Market Trends 2011
10/17/2011 | published by: Select Biosciences Limited
... qualitative and quantitative trends from the bottom-up. This report analyzes the microRNA marketplace from a market perspective describing the market trends operative in this space, quantitative penetrance of vendors in the microRNA products space [for ...
|
read more...
|
$1,720.00
|
|
Personalized Medicine for Cancer
9/30/2011 | published by: GlobalData
... The report also provides insights on the companion diagnostics and marketed personalized drugs for cancer. Scope The report provides information on the concept of personalized medicines, Challenges in development of personalized medicine and Benefits of ...
|
read more...
|
$500.00
|
|
Sample Preparation in Genomics, Proteomics, and Epigenomics: Global Markets
9/1/2011 | published by: BCC Research
... estimates for 2011, and projections of compound annual growth rates (CAGRs) through 2016 A breakdown of the sample preparation market by subcategories, including next-generation sequencing, microarrays, qPCR and PCR, RNA research, and synthetic biology Coverage ...
|
read more...
|
$5,450.00
|
|
Biobanks
9/1/2011 | published by: Global Industry Analysts
... through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 251 companies including many key and niche players such as Service Providers - Asterand PLC, CBR Systems, Inc., Cord Blood ...
|
read more...
|
$4,200.00
|
|
Competitor Analysis: Novel Mitotic Kinase Inhibitors
9/1/2011 | published by: La Merie Publishing
... as of September 2011. Purchase of the downloadable pdf report includes a 6-month online access to the data of the report and any updates since the publication date. Credentials to access the database will be ...
|
read more...
|
$550.00
|
|
Report: Do the Emerging Treatments for Celiac Disease Offer Significant Improvements over the Gluten-Free Diet?
9/1/2011 | published by: Decision Resources
... these patients—a gluten-free diet. Interviewed experts watch with interest the clinical development of other therapies for celiac disease patients. This market presents a substantial opportunity for drug developers. Questions Answered * A gluten-free diet is ...
|
read more...
|
$9,200.00
|
|
Biomarker Technology Platforms for Cancer Diagnoses and Therapies
9/1/2011 | published by: TriMark Publications
... types such as lung, breast, colon and prostate, long-term survival rates drop precipitously once metastatis has occurred. The case is clear for development of biomarkers for early detection and screening tests for diseases such as ...
|
read more...
|
$3,400.00
|
|
Apoptosis
9/1/2011 | published by: Global Industry Analysts
... provided for the period 2009 through 2017. Also, a six-year historic analysis is provided for these markets. The report profiles 114 companies including many key and niche players such as Abbott Laboratories, AbGenomics International, Inc., ...
|
read more...
|
$4,200.00
|
|
Metabolomics
8/1/2011 | published by: Global Industry Analysts
... the period 2008 through 2017. The report profiles 45 companies including many key and niche players such as Agilent Technologies, Inc., Avogadro, BG Medicine, Inc., Biocrates Life Sciences AG, Bio-Rad Laboratories, Inc., Bruker Corporation, Chenomx, ...
|
read more...
|
$4,500.00
|
|
Global Biochip Markets: Microarrays and Lab-on-a-Chip
8/1/2011 | published by: BCC Research
... by 2016, a compound annual growth rate (CAGR) of 19.5%. Tools markets for biochips will experience slowing growth due to maturation of some market segments-including gene expression analysis and single nucleotide polymorphism (SNP) genotyping. This ...
|
read more...
|
$5,450.00
|
|
Opportunities and Key Players in Medical Nutrition
7/29/2011 | published by: Business Insights
... depth. This report examines the potential of this burgeoning market by identifying areas of unmet need and the companies looking to cater to this demand with new product development. Features and benefits Explore the medical ...
|
read more...
|
$4,795.00
|
|
Perspective: The Emerging Commercial Genomics Frontier - BGI Leads the Way
7/18/2011 | published by: IDC
... aspiration of the $1,000 genome rapidly becoming reality, research and service organizations involved in genomics need to expand their focus beyond the academic roots of whole genome sequencing (WGS) to more commercial, process-oriented efforts designed ...
|
read more...
|
$1,500.00
|
|
Conference Documentation: Biobanking
7/12/2011 | published by: SMI Publishing, Ltd
... With a key focus on bridging the gap between the world’s leading academia and the pharma industry, Biobanking provides the perfect forum to successfully build essential frameworks for future research and drug development. Developing communication ...
|
read more...
|
$800.00
|
|
DNA Molecules Simulate Neural Net Behaviors Caltech Research Gets DNA NNs to Recall Memories from Patterns
7/1/2011 | published by: Intelligence - The Future of Computing
... brain can. Consisting of four artificial neurons made from 112 distinct DNA strands, the researchers’ NN plays a mind-reading game in which it tries to identify a mystery scientist. The researchers “trained” the NN to ...
|
read more...
|
$395.00
|
|
Next Generation Sequencing Generates Momentum
6/1/2011 | published by: CHI Insight Pharma Reports
... new scaled-down instruments to broaden the market? What Generation 2.5 systems featuring new detection technologies and single-molecule sequencing are now on the market? When will third generation of instruments led by nanopore technologies be entering ...
|
read more...
|
$3,195.00
|
|
Biobanking: Technologies and Global Markets
6/1/2011 | published by: BCC Research
... breakdown of the markets that will cover the U.S., the European Union, Asia, and the rest of the world Examinations of applications detailed by Biomarker Identification, Recurrence Risk, Sample Storage, Predisposition Risk, and Trial Effectiveness ...
|
read more...
|
$5,450.00
|
|
Genomic Sequencing Technologies for Medicine: Market Prospects 2011-2021
5/3/2011 | published by: Visiongain
... an emphasis on pharma R&D. We aim to save you time and aid your decisions through our research, analysis and discussions. Our new study shows you revenue prospects for genomic technologies at total world, submarket, ...
|
read more...
|
$2,416.00
|
|
Next Generation Sequencing: Opportunities, Trends and World Market
5/1/2011 | published by: Takeda Pacific
... sequencing drops to $1,000 or less, scientists will be able sequence human genomes at the massive scale needed to better understand human variation and help open the gateway to personalized medicine. New NGS markets in ...
|
read more...
|
$2,595.00
|
|
Forensic Technologies: New and Growing Markets
5/1/2011 | published by: BCC Research
... with data from 2010, estimates for 2011, and projections of compound annual growth rates (CAGRs) through 2016 Examinations of technological issues, including the latest trends and a thorough patent analysis An overview of the hundreds ...
|
read more...
|
$5,450.00
|
|
Single Cell Omics 2011
5/1/2011 | published by: Select Biosciences Limited
... the next confound researchers and force them to average results into irrelevance. Researchers may find, in fact, that this variability is critical for cells to respond to and interact with their environments. But even without ...
|
read more...
|
$4,215.00
|
|
Global DNA & Gene Chip (Microarray) Market (2010 - 2015)
5/1/2011 | published by: MarketsandMarkets
... Gene Chip (microarray) market was valued at $760 million in 2010 and is expected to reach $1,425.2 million by 2015 growing at a CAGR of and 13.4%. The oDNA segment accounted for the largest share ...
|
read more...
|
$4,650.00
|
|
Exploiting Information Technology Tools to Advance Personalized Medicine
5/1/2011 | published by: Decision Resources
... information; the need for patients, physicians, and biopharmaceutical companies to be connected; and the overall desire by governments to explore newer and cost-effective ways to deliver healthcare, IT is indeed a driving force that will ...
|
read more...
|
$4,600.00
|
|
Genetic Testing Reagents - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017
4/5/2011 | published by: GlobalData
... information and analysis on the global genetic testing market. The report provides market landscape, competitive landscape and market trends information on the genetic testing market. The report provides comprehensive information on the key trends affecting ...
|
read more...
|
$3,500.00
|

